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uropean Antibiotic Awareness Day (EAAD) is marked annually on 18 November to highlight the importance of prudent antibiotic use and the major threat to public health caused by antibiotic resistance. Organised by the European Centre for Disease Prevention and Control (ECDC) , with the support of European Union professional organisations and health networks, its intent is to galvanise countries to use this day to raise awareness among healthcare workers and the public of their shared responsibilities to reduce the use of antibiotics and preserve this precious resource.
Before 1943, the so-called 'pre-antibiotic' era, a relatively simple infection was very likely to prove fatal and healthcare workers were powerless to help. How likely is the scenario of a chillingly similar 'post-antibiotic era'? Unlikely? Perhaps not so unlikely -and some experts may argue that we are approaching a 'perfect storm' of conditions that could lead to such a scenario. Fewer and fewer new antibiotic agents are being developed and, although there are some new agents in development, no new class of antibiotics has been brought into clinical use since the 1980s. Dr Margaret Chan, Director General of the World Health Organization (WHO), sums the situation up well, 'In terms of new replacement antibiotics, the pipeline is virtually dry' (WHO, 2013) . Many of the new agents being developed have a narrow spectrum of action, limited efficacy, or problems with toxicity. For example, Appelbaum (2012) reports that there is no sign of new treatment options emerging in the near future for some types of infection in children. The need for governmental and industry action to develop new agents is clear, but this must be combined with the prudent use of current antibiotics to slow the development of resistance. Action must also be combined with a heightened emphasis on high quality infection prevention and control to prevent the spread of existing resistant strains and this is where the Infection Prevention Society and its extensive network of members has the potential to play a comprehensive and important role in the future.
In 2011, the WHO dedicated its World Health Day to antimicrobial resistance with a strap line of 'No Action Today, No Cure Tomorrow' (WHO, 2012) and highlighted infection prevention and control as one of six key areas where action is required now to combat future threats to health associated with resistance. The acknowledgement of the importance of antimicrobial resistance is crucial, but it is essential that this be supported by country-level action to achieve any impact. Similar to many countries across Europe, the United Kingdom (UK) and the Republic of Ireland have clear strategies to tackle the problems associated with antibiotic resistance. In England, the Chief Medical Officer (CMO), Professor Dame Sally Davies, devoted the second volume of her recent annual report to the problem, including a call to place antibiotic resistance on the national risk register as a major threat to public health (CMO, 2013) . In September 2013, the Department of Health (DH) published the 'UK Five Year Antimicrobial Resistance Strategy 2013 to 2018' (DH, 2013) , which encompasses antibiotic use and resistance in both human and animal health. The Republic of Ireland has its equivalent approach in its 'Strategy for the control of Antimicrobial Resistance in Ireland' (SARI; Health Protection Surveillance Centre, 2011). These strategies have common themes of importance to infection prevention and control teams, other health and social care workers, and to the general public.
A number of initiatives have been launched successfully worldwide over the past years, including Antibiotic Action (http://antibiotic-action.com), 'The Chennai Declaration' issued by a Joint Meeting of Medical Societies in India (http://www.reactgroup.org/ uploads/images/News/The-Chennai-declaration.pdf), and 'The Paris Declaration of WAAR (World Alliance again Antibiotic Resistance)' (http://www.infectiologie.com/site/medias/_documents/ ATB/waaar/waaar-2013-09-05.pdf).
Themes contained in the UK strategy (DH, 2013) relate to improved knowledge and understanding of antimicrobial resistance, conservation and stewardship in relation to existing treatments with a particular emphasis on infection prevention and control, and stimulating innovation and investment in new drugs, diagnostics, and therapies. Infection prevention teams and their colleagues and networks will play a vital role in the first two of these themes and the Infection Prevention Society, in collaboration with our strategic partners, can add the voice of infection prevention specialists to the growing call for action on the third. I cannot emphasise too strongly the contribution of infection prevention and control to this increasingly vital public health agenda. Infection prevention and control teams are inherently multidisciplinary and together with professionals from nursing, medicine, infectious diseases, microbiology, and pharmacy backgrounds, they have the potential to drive change in prescribing practice across all settings. Nevertheless, the evidence suggests that there is much more to be done and the consequences in the event of failure will be very clear to our colleagues already working to control the spread of multiresistant bacteria in their facilities and limit the adverse effects of antibiotic use, such as infections with Clostridium difficile. For example, the most recent Europe-wide data on antimicrobials for surgical prophylaxis show that every participating country (n=33) gave surgical prophylaxis for more than one day to a proportion of those receiving prophylaxis (ECDC, 2013) .
The importance of preventing the spread of resistance through effective infection prevention and control action must be tackled locally, nationally, and internationally -antimicrobial resistance and infection do not recognise or respect national borders. Hand hygiene at the right moment remains at the core of infection prevention and is central to all infection prevention strategies (WHO, 2009) . In addition to hand hygiene, the recent WHO publication (2012) on antimicrobial resistance reminds us of the need for a multifaceted approach to infection prevention that includes a combination of some or all of the following, tailored to the organism and the local context: contact precautions; screening measures; readmission alert systems; patient placement; decolonisation; and education and environmental cleaning. As we approach EAAD 2013, we have an opportunity to leverage the day to raise awareness and contribute to action on antimicrobial resistance that will have an impact and I call on all readers to give the day their full support.
Note IPS will be promoting EAAD through Twitter using #EAAD Follow @ECDC_EU to keep track of activities leading up to and on the day.
Visit the EAAD Facebook pages for more information https:// www.facebook.com/EAAD.EU
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